author-photo

A. Golembesky

Boehringer Ingelheim

12

Papers

94

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists

2021 Dermatologic Therapy
Show All
- Source
- Cite
- Save
Citations (2)
The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review

2020 Expert Review of Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (10)
1532PAfatinib followed by osimertinib in patients with EGFR mutation-positive (EGFRm+) advanced NSCLC: Updated data from the GioTag real-world study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PCN134 RETROSPECTIVE CLAIMS ANALYSIS OF TREATMENT DURATION, HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH FIRST-LINE TREATMENT OF NSCLC WITH AFATINIB VS. ERLOTINIB IN THE UNITED STATES

2019 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA

2019 Future Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study

2019 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (1)
LBA7Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag)

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)